Dr. Robert Ramak Attaran, FACC, MD

Dr. Attaran practices at Yale Medicine in New Haven, Connecticut.

Dr. Attaran's NPI, 1629270616, was assigned on June 3, 2007. Dr. Attaran graduated from University of Sheffield School of Medicine in 2000. Dr. Attaran's Connecticut license number on file is 052939.

Dr. Attaran's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Attaran's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Attaran is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Attaran to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Attaran practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Attaran's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Attaran is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Attaran's licenses on file in 4 states: Connecticut, New York, Florida and Arizona.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, chronic embolism thrombosis, chronic hypertension, chronic skin ulcer and circulation problems among the conditions Dr. Attaran treats.

CMS data shows 463 Medicare services from Dr. Attaran across 11 procedure codes in 2024, for 255 Medicare patients. Medicare paid $30,317 for them.

CMS counts 255 Medicare patients who saw Dr. Attaran in 2024. The largest group is 75 to 84, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Attaran's median patient age at 75, with 42% women.

In 2024, Dr. Attaran wrote 1,575 Medicare Part D claims for 231 patients. 84% of them were for generic drugs. CMS names the drug for 1,343 of them, across 28 drugs with 11 or more claims each, at $250,689 in total drug cost. In 2023, CMS named 1,024 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Attaran for performance year 2024, reported as part of a group. Dr. Attaran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Attaran as offering telehealth. CMS counts 15 procedures of varicose vein removal by Dr. Attaran, more than 51% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 60 papers to Dr. Attaran, published from 2006 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Peripheral Arterial Disease, Stents and Endovascular Procedures. Dr. Attaran has published most often in J Vasc Surg Venous Lymphat Disord. Dr. Attaran's most frequent co-authors are Carlos I. Mena-Hurtado, MD, Costin Nicolae Ionescu, MD, PhD and Herbert David Aronow, MD.

Dmand AI links Dr. Attaran to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 110 general payments to Dr. Attaran from 15 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 31% of the total. Medtronic Vascular, Inc. paid the most, $7,058.

Dmand AI lists 5 awards for Dr. Attaran.

Dr. Attaran graduated from University of Sheffield School of Medicine in 2000. Dr. Attaran is a member of ACC, ASE and Society for Coronary Angiography and Interventions.

Dr. Attaran is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.